​

Funding Round

Series C - G1 Therapeutics

Series C - G1 Therapeutics

Investment Firm

Overview

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.

Announced Date

May 11, 2016

Closed on Date

May 11, 2016

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

11

Investor Name
Participant InvestorRA Capital Management
Participant InvestorMountain Group Capital
Participant InvestorMedImmune Ventures
Participant InvestorHatteras Venture Partners
Participant InvestorFranklin Templeton

Round Details and Background

G1 Therapeutics raised $47000000 on 2016-05-11 in Series C

G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 05, 2015
Series B - G1 Therapeutics
7-33.0M
Oct 16, 2013
Series A - G1 Therapeutics
3-12.6M
Oct 12, 2012
Venture Round - G1 Therapeutics
-762.9K
Apr 18, 2013
Debt Financing - G1 Therapeutics
-457.9K

Recent Activity

There is no recent news or activity for this profile.